Rankings
▼
Calendar
IONS Q4 2023 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$13B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$325M
+113.6% YoY
Gross Profit
$321M
99.1% margin
Operating Income
-$6M
-1.9% margin
Net Income
-$9M
-2.9% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
+125.0%
Cash Flow
Operating Cash Flow
$33M
Free Cash Flow
$34M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$3.0B
Total Liabilities
$2.6B
Stockholders' Equity
$387M
Cash & Equivalents
$399M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$325M
$152M
+113.6%
Gross Profit
$321M
$148M
+116.9%
Operating Income
-$6M
-$208M
+97.1%
Net Income
-$9M
-$52M
+82.3%
Revenue Segments
Research and Development Revenue
$246M
36%
Collaborative Agreement Revenue
$179M
26%
SPINRAZA Royalties
$112M
16%
Commercial
$79M
12%
Other Commercial
$34M
5%
Product
$20M
3%
Licensing and Other Royalties
$14M
2%
← FY 2023
All Quarters
Q1 2024 →